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Editorial on the Research Topic
4th Applied Synthetic Biology in Europe
The congress of Applied Synthetic Biology in Europe was the 4th of this kind to be organized under
the auspices of the European Federation of Biotechnology in Toulouse from 24 to 27 October
2018. It gathered about 130 participants from all over Europe as well as some participants from
Asia, Brazil, and USA. Five sessions encompassing main disciplines in Synthetic Biology were on
the program, and we acknowledged receiving several contributions by many of the participants
to this meeting in each of these sessions. The sessions that received the most contributions were
those dealing with topics in synthetic pathways for bio (chemical) manufacturing and synthetic
biology for biotechnology applications. Relevant in these reports were concerns about pathways
design and reconstruction, sometimes guided by computational analysis to propose non-natural
metabolic routes for maximal yield and the choice of the more appropriate microorganism as
potential industrial producer. In this regard, the production of trans-cinnamate from glucose
was achieved by rational engineering of L-phenylalanine accumulation in Pseudomonas taiwensis
since this bacteria is much more tolerant than E. coli to this non-natural product (Otto et al.).
However, toxicity of this product remains a serious bottleneck in order to reach economically
viable titers and yields of t-cinnamate from sugars, which might be overcome by application of
adaptive laboratory evolution. As a well-established microbial platform for fatty acid accumulation
(Blazeck et al., 2015), the oleaginous Yarrowia lipolytica was engineered for de novo biosynthesis
of odd fatty acid from inexpensive carbon source (Park et al.). The critical point in this work
was to enable an endogenous supply of propionyl-CoA as the key precursor for the synthesis
of these fatty acids. These authors brought this capability to the yeast cell by the expression of
a modular pathway with seven enzymatic steps that employed the threonine biosynthetic route
and its deamination into α-ketobutyrate. The industrial potential of this strategy will await further
improvement in the specificity and activity of the decarboxylating enzyme on α-ketobutyrate as
well as enhancement of carbon fluxes to propionyl-coA through metabolic engineering tools. Two
other papers in this session were dedicated to implement non-natural pathways to produce bio-
based products from C5 and C6 sugars at the highest yield. Bator et al. compared in silico and in
vivo the synthetic capabilities of three metabolic routes, namely the xylose isomerase, the Dahms
and the Weimberg pathways for xylose metabolization into a wide variety of valuable products
in Pseudomonas putida KT2240. The computational analysis with flux balance analysis (FBA)
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indicated highest yield of 12 out of the 14 value products
by the isomerase pathway, which was confirmed in vivo for
the production of mono-rhamnolipids and pyocyanin. While
reinforcing the usefulness of FBA to guide pathway design,
the limitation of these in silico methods is that they cannot
predict best productivity and titer. Ultimately, the work showed
that higher production rate and titer were obtained with the
Weimberg pathway for these high value products. Product yield
higher than those calculated from the stoichiometry of natural
pathways can be obtained by pathway reconstruction in which
loss of carbon as CO2 is avoided, as recently shown for the
construction of the “NOG” pathway (Bogorad et al., 2013) and
reviewed by François et al.. Along this line, Lachaux et al. devised
a cyclic pathway enabling optimal conversion of C5 and C6
carbon into glycolic acid by reallocating the function of two
E.coli kdsD and fsaA genes encoding arabinose-5-P isomerase
and fructose-6-P aldolase, respectively, in combination with the
non-oxidative pentose pathway. Altogether, these contributions
illustrate the trend of integrating systems biology, synthetic
biology, and evolutionary engineering with traditional metabolic
engineering to expedite the development of relevant microbial
cell factories for the production of bio-based products from
renewable carbon sources, as the cornerstone of the emerging
Bio-Economy. However, there is still a gap to be filled in to
make these strains industrially competitive and the attendant
fermentation processes economically viable. Notably, better
knowledge of the management of the cellular energy and redox
balance by metabolic engineering as reviewed in Kalnenieks
et al. for the ethanologenic bacterium Zymomonas mobilis and
development of analytical tools for rapid screening of products
yield, such as sensing and monitoring production of benzoic
derivatives by mean of a biosensor (Castaño-Cerezo et al.)
are important to make rapid progress in this applied field of
Synthetic Biology.
Generation and investigation of biological functions can
be in in vitro systems using cell-free systems that rests
on the use of cell free protein synthesis (CFPS). Pioneered
by Nirenberg and Matthaei (1961) to elucidate the genetic
code, cell-free systems are gaining more and more credit
in the field of Synthetic Biology as a prototype platform
to engineer biological parts at levels of protein, metabolism
and cell (Shimizu et al., 2006; Hodgman and Jewett, 2012;
Moore et al., 2017). Cell free synthetic biology was particularly
emphasized in the session “Biosciences and Bionanoengineering’
with several contributions. Spice et al. reported on the
synthesis and assembly of hepatitis B virus-like particles (VLP)
using cell-free system prepared from Pichia pastoris, which
can represent an alternative approach to the production of
VLP for therapeutic purposes. On the other hand, Gabant
and Borrero exploited cell-free protein synthesis system as
a rapid method to expedite production and validation of a
large set of bacteriocin, which are cataloged into a database,
termed “PARAGEN1.0.” Cell free system is also suggested
as an alternative strategy for engineering and production
of organophosphorus hydrolysing enzymes to be used to
decontaminate highly toxic agricultural pesticides and chemical
warfare (Thakur et al.). In addition, these authors make
a thorough overview on the practice that are currently
used for decontaminating environments and seawater from
toxic organophosphorus compounds, emphasizing on the
need to strongly enhance catalytic activity and stability
of these organophosphorus hydrolysing enzymes by various
bionanoengineering approaches.
Genome editing, genome engineering, and synthetic genomics
are among the most disruptive technology at the heart of
Synthetic Biology. A contribution to this session was a paper
by Millacura et al. who report on a cell-based logic system
termed ParAlleL that allows to construct complex logic circuits
enable to respond to a combination of inputs. They demonstrate
their concept through the construction of three simple logic
circuits, a 1-bit full adder, a 1-bit subtractor, and a numeric
display. Experimentally, the concept was shown by transforming
E. coli with three out of six plasmids to make them able
to survive only when precisely three antibiotics are provided.
This represents an interesting way of constructing circuits
from cellular populations in which logic is constructed and
circuitry functionality displayed simply by the surviving cells
in the presence of antibiotics. Very challenging in genetic
and genome engineering is to build efficient and robust gene
expression leading to high protein production, for instance.
Eichmann et al. tentatively solved the problem of expression
and production of so-called three difficult-to-express proteins
by systematic evaluation of ribosome binding sites, N-terminal
affinity tags and periplasmic translocation sequences to which
was fused green fluorescent protein (GFP) to identify high
producers by fluorescence activated cell screening (FACS).
Large combinatorial libraries of genes were expressed and the
outcome was measured in a platform monitoring expression
automatically. Though yields were still low, this work unraveled
that TAT-dependent signal sequence from E. coli YahJ for
expression is recognized in the fast-growing bacterium Vibrio
natriegens, which could be used as an industrial platform for
production of recombinant proteins.
This editorial can be concluded by referring to the article
by El Karoui et al. which reports on a workshop that brought
together British academics and industrialists at the University
of Edinburgh to discuss the future of synthetic biology. If
processes that underlie all living systems can be manipulated,
modified or reshaped using the tools of Synthetic Biology,
then in return we need to take the public with us on this
journey to create a productive dialogue about the work we can
do and the impact it can have on our world and our way
of life.
AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct and intellectual
contribution to the work, and approved it for publication.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 2 May 2020 | Volume 8 | Article 431
François et al. 4th ASBE
REFERENCES
Blazeck, J., Hill, A., Jamoussi, M., Pan, A., Miller, J., and Alper, H.S.
(2015). Metabolic engineering of Yarrowia lipolytica for itaconic
acid production. Metab. Eng. 32, 66–73. doi: 10.1016/j.ymben.2015.
09.005
Bogorad, I. W., Lin, T. S., and Liao, J. C. (2013). Synthetic non-oxidative
glycolysis enables complete carbon conservation. Nature 502, 693–697.
doi: 10.1038/nature12575
Hodgman, C. E., and Jewett, M. C. (2012). Cell-free synthetic biology:
thinking outside the cell. Metab. Eng. 14, 261–269. doi: 10.1016/j.ymben.2011.
09.002
Moore, S. J., Macdonald, J. T., and Freemont, P. S. (2017). Cell-free synthetic
biology for in vitro prototype engineering. Biochem. Soc. Trans. 45, 785–791.
doi: 10.1042/BST20170011
Nirenberg, M. W., and Matthaei, J. H. (1961). The dependence of cell-free protein
synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides.
Proc. Natl. Acad. Sci. U.S.A. 47, 1588–1602.
Shimizu, Y., Kuruma, Y., Ying, B. W., Umekage, S., and Ueda, T. (2006). Cell-
free translation systems for protein engineering. FEBS J. 273, 4133–4140.
doi: 10.1111/j.1742-4658.2006.05431.x
Conflict of Interest: JJ was employed by company VTT Technical Research
Centre of Finland.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2020 François, Jantti and Daboussi. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 3 May 2020 | Volume 8 | Article 431
